|Articles|October 12, 2020
Characterization of Viral Vector Particles Using the Agilent 6545XT AdvanceBio LC/Q-TOF
Author(s)Agilent Technologies
Workflow for the characterization of critical quality attributes (CQAs) of intact adeno-associated viruses (AAVs), together with identification of the capsid proteins.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How Biopharma Navigates the 2026 Economic Shift
2
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
3
Adenovirus Vectors, Cyclodextrins and the Patient Experience: A Deep Dive
4
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
5